BONE AND RENAL SAFETY ARE IMPROVED IN CHRONIC HBV PATIENTS 1 YEAR AFTER SWITCHING TO TENOFOVIR ALAFENAMIDE (TAF) FROM TENOFOVIR DISOPROXIL FUMARATE (TDF)


Chan H. L. Y. , Seto W. K. , Buti M., Izumi N., Lim Y., Kao J., ...Daha Fazla

International Digestive Disease Forum (IDDF), Hong Kong, Hong Kong, 8 - 09 Haziran 2019, cilt.68 identifier